相似文献
1
Oral Glucose Tolerance Test: An Informative Endpoint or an Added Burden in Metformin Drug-Drug Interaction Studies?
Clin Pharmacol Ther. 2022 Sep;112(3):453-455. doi: 10.1002/cpt.2650. Epub 2022 Jun 10.
2
The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Pediatrics. 2001 Apr;107(4):E55. doi: 10.1542/peds.107.4.e55.
3
Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes.
Diabetes Care. 2005 Feb;28(2):266-72. doi: 10.2337/diacare.28.2.266.
4
5
Metformin: diamonds are forever.
Expert Opin Pharmacother. 2009 Oct;10(15):2395-7. doi: 10.1517/14656560903176453.
6
Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
J Am Heart Assoc. 2020 Jan 7;9(1):e012940. doi: 10.1161/JAHA.119.012940. Epub 2020 Jan 4.
7
Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
Diabetes Obes Metab. 2004 Jan;6(1):8-15. doi: 10.1111/j.1463-1326.2004.00306.x.
8
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
9
Metformin and daclatasvir: absence of a pharmacokinetic-pharmacodynamic drug interaction in healthy volunteers.
Br J Clin Pharmacol. 2017 Oct;83(10):2225-2234. doi: 10.1111/bcp.13323. Epub 2017 Jun 6.
10
Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
Metabolism. 2013 Sep;62(9):1330-9. doi: 10.1016/j.metabol.2013.05.001. Epub 2013 Jul 4.
引用本文的文献
1
Pharmacological characterization of the antidiabetic drug metformin in atherosclerosis inhibition: A comprehensive insight.
Immun Inflamm Dis. 2024 Aug;12(8):e1346. doi: 10.1002/iid3.1346.
2
Effects of metformin on the glucose regulation, lipid levels and gut microbiota in high-fat diet with streptozotocin induced type 2 diabetes mellitus rats.
Endocrine. 2024 Oct;86(1):163-172. doi: 10.1007/s12020-024-03843-y. Epub 2024 May 23.
3
Metformin role in Parkinson's disease: a double-sword effect.
Mol Cell Biochem. 2024 Apr;479(4):975-991. doi: 10.1007/s11010-023-04771-7. Epub 2023 Jun 2.
4
GC-MS analysis and pharmacological evaluations of (Roxb.) seeds provide new insights into the management of oxidative stress and hyperglycemia.
Food Sci Nutr. 2022 Dec 21;11(3):1553-1562. doi: 10.1002/fsn3.3196. eCollection 2023 Mar.
本文引用的文献
1
Rifampicin Alters Metformin Plasma Exposure but Not Blood Glucose Levels in Diabetic Tuberculosis Patients.
Clin Pharmacol Ther. 2019 Mar;105(3):730-737. doi: 10.1002/cpt.1232. Epub 2018 Oct 29.
2
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment Decision.
Clin Pharmacol Ther. 2018 Nov;104(5):781-784. doi: 10.1002/cpt.1082. Epub 2018 May 15.
3
Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers.
Br J Clin Pharmacol. 2014 Dec;78(6):1426-32. doi: 10.1111/bcp.12476.
4
Rifampin enhances the glucose-lowering effect of metformin and increases OCT1 mRNA levels in healthy participants.
Clin Pharmacol Ther. 2011 Mar;89(3):416-21. doi: 10.1038/clpt.2010.266. Epub 2011 Jan 26.
5
Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions.
Pharmacogenomics J. 2011 Dec;11(6):400-11. doi: 10.1038/tpj.2010.54. Epub 2010 Jun 22.
6
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action.
J Clin Invest. 2007 May;117(5):1422-31. doi: 10.1172/JCI30558.
7
Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.
J Clin Pharmacol. 1996 Nov;36(11):1012-21. doi: 10.1177/009127009603601105.
8
Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.
Diabetologia. 1996 Mar;39(3):298-305. doi: 10.1007/BF00418345.
9
Use of a standard preparatory diet for the oral glucose tolerance test. Is it necessary?
J Reprod Med. 1991 Feb;36(2):147-50.
10
Study in Tanzania of impaired glucose tolerance. Methodological myth?
Diabetes. 1991 Apr;40(4):516-20. doi: 10.2337/diab.40.4.516.
Zotero 插件